IRIS
ZITO MARINO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.140
AS - Asia 1.931
NA - Nord America 1.782
SA - Sud America 355
AF - Africa 38
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.250
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.710
RU - Federazione Russa 1.468
SG - Singapore 648
IE - Irlanda 547
IT - Italia 506
HK - Hong Kong 433
CN - Cina 361
BR - Brasile 309
DE - Germania 165
KR - Corea 136
GB - Regno Unito 130
VN - Vietnam 105
JP - Giappone 100
UA - Ucraina 80
CA - Canada 56
IN - India 56
FR - Francia 46
GR - Grecia 43
FI - Finlandia 39
TR - Turchia 21
AT - Austria 20
SE - Svezia 19
AR - Argentina 14
BE - Belgio 14
NL - Olanda 13
ZA - Sudafrica 12
MX - Messico 11
CH - Svizzera 10
PK - Pakistan 10
IQ - Iraq 8
MA - Marocco 8
PH - Filippine 8
BD - Bangladesh 7
EC - Ecuador 7
PY - Paraguay 7
MK - Macedonia 6
PL - Polonia 6
VE - Venezuela 6
BJ - Benin 5
CZ - Repubblica Ceca 5
ES - Italia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BG - Bulgaria 4
CL - Cile 4
ID - Indonesia 4
AU - Australia 3
CO - Colombia 3
DK - Danimarca 3
IL - Israele 3
KE - Kenya 3
NP - Nepal 3
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
EG - Egitto 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 7.250
Salva come PNG Salva come JPEG
Città #
Dublin 543
Moscow 513
Hong Kong 432
Santa Clara 323
Singapore 307
Chandler 263
Seoul 135
Jacksonville 130
Naples 125
Ashburn 75
Princeton 66
Roxbury 66
Beijing 64
Munich 57
Hefei 54
Dallas 50
Bremen 45
Bengaluru 41
Ho Chi Minh City 37
Medford 37
New York 37
Elora 36
São Paulo 33
Cambridge 29
The Dalles 29
Aversa 28
Los Angeles 27
Caserta 26
Des Moines 23
Ercolano 21
Nuremberg 21
Hanoi 18
Napoli 18
Wilmington 18
Boardman 15
Brussels 14
Brooklyn 11
Grumo Nevano 11
San Francisco 11
Rio de Janeiro 10
Woodbridge 10
Falkenstein 9
Tokyo 9
Vienna 9
Brasília 8
Da Nang 8
Helsinki 8
Lappeenranta 8
Rome 8
Seattle 8
Biên Hòa 7
Columbus 7
Düsseldorf 7
Haiphong 7
Portici 7
Tianjin 7
Afragola 6
Ann Arbor 6
Asunción 6
Johannesburg 6
Nanchang 6
Stockholm 6
Volla 6
Warsaw 6
Amsterdam 5
Ariano Irpino 5
Belo Horizonte 5
Castellammare di Stabia 5
Changsha 5
Chennai 5
Council Bluffs 5
Curitiba 5
Falls Church 5
Goiânia 5
Guangzhou 5
Jinan 5
Ninh Bình 5
San Giuliano 5
Shanghai 5
Tashkent 5
Turku 5
Atlanta 4
Baku 4
Boydton 4
Hangzhou 4
Istanbul 4
Lausanne 4
Manassas 4
Mexico City 4
Montreal 4
Norwalk 4
Ottawa 4
Recife 4
San Mateo 4
Sofia 4
Toronto 4
Trieste 4
Berlin 3
Boston 3
Brno 3
Totale 4.132
Salva come PNG Salva come JPEG
Nome #
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas 132
Adequacy of Cytologic Samples by Ultrasound-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology of Peripheral Pulmonary Nodules for Morphologic Diagnosis and Molecular Evaluations: Comparison With Computed Tomography-Guided Percutaneous Transthoracic Fine-Needle Aspiration Cytology 130
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? 124
Predictive biomarkers along gastric cancer pathogenetic pathways 122
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 121
A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse Large B-cell Lymhpoma with immature features or B-cell Lymhpoblastic Lymphoma? 116
Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry 115
Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? 113
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 110
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer 109
Cytologic diagnosis of metastatic melanoma by FNA: A practical review 109
Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs. 103
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR 102
Immunotherapy in Penile Squamous Cell Carcinoma: Present or Future? Multi-Target Analysis of Programmed Cell Death Ligand 1 Expression and Microsatellite Instability 99
Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies 99
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 99
AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma 98
ALK Rearrangement in Lung Cancer: Is Patients Filtering Possible 98
Interventional cytopathology in COVID-19 ERA 98
Discrepancy of p16 immunohistochemical expression and HPV RNA in penile cancer. A multiplex in situ hybridization/immunohistochemistry approach study 98
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in Italy 97
To Get the Most out of the Least: BRAF Molecular Evaluation in Melanoma Metastases on Cell Suspension from Fine Needle Aspiration Cytology Needle Rinses 97
A new look at the ALK gene in cancer: copy number gain and amplification 97
Aberrant signaling through the HER2-ERK1/2 pathway is predictive of reduced disease-free and overall survival in early stage non-small cell lung cancer (NSCLC) patients 97
The potential diagnostic and predictive role of anaplastic lymphoma kinase (ALK) gene alterations in melanocytic tumors 97
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 96
Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival 96
Circulating tumor cells as emerging tumor biomarkers in lung cancer. 95
GOLPH3 promotes oncogenesis by controlling the intra-Golgi trafficking of glycosphingolipid synthases 93
A Critical Issue in Lung Cancer Cytology and Small Biopsies: DNA and RNA Extraction from Archival Stained Slides for Biomarker Detection through Real Time PCR and NGS-The Experience in Pathological Anatomy Unit 93
Preliminary Experience of Liquid Biopsy in Lung Cancer Compared to Conventional Assessment: Light and Shadows 92
HER2 EXPRESSION IN GASTROINTESTINAL TUMOR. A FOCUS ON DIAGNOSTIC ALGORITHM OF HER2. STATUS FROM GASTRIC TO INTESTINAL CANCER 91
Second Diagnostic Opinion by Experienced Dermatopathologists in the Setting of a Referral Regional Melanoma Unit Significantly Improves the Clinical Management of Patients With Cutaneous Melanoma 91
Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 86
Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond 86
Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma 85
PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples 85
Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC 84
Application of CytoMatrix for the diagnosis of melanoma metastases on FNA cytology samples: Performance of a novel cell block method 83
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 83
Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients 82
AXL, c-MET and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma 82
MALT GASTRIC LYMPHOMA: AN UPDATE OF PATHOGENETIC FEATURES 81
Correction: Intratumor heterogeneity of ALK-rearrangements and homogeneity of EGFR-mutations in mixed lung adenocarcinoma 81
Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study 80
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors: A comprehensive analysis with clinicopathologic and molecular correlations 80
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 80
Diagnostic accuracy of FNA cytology for diagnosis of salivary gland tumors in pediatric patients 80
Extragonadal germ cell tumors: Not just a matter of location. A review about clinical, molecular and pathological features 80
Concomitant ALK/KRAS and ALK/EGFR mutations in non small cell lung cancer: Different profile of response to target therapies 80
Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers 80
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 79
Analysis of microsatellite instability (MSI) in pediatric gonadal and extra-gonadal germ cell tumors 79
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV 78
Skin Adnexal Tumours: A Large Spectrum of Clinic-Pathological Lesions 77
New therapeutic perspectives in CCDC6 deficient lung cancer cells 76
Mesenchymal neoplasms: Is it time for cytology? New perspectives for the pre-operative diagnosis of soft tissue tumors in the molecular era 76
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 74
Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features 74
The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems 73
Immunohistochemistry for Cancer Stem Cell Detection: Principles and Methods 73
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 73
How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls 72
Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous Carcinomas 69
CRISPR-barcoding in non small cell lung cancer: From intratumor genetic heterogeneity modeling to cancer therapy application 69
Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma 68
Mitochondrial AKAP1 supports mTOR pathway and tumor growth 68
Primary and secondary cutaneous angiosarcoma: Distinctive clinical, pathological and molecular features 68
The GOLPH3 oncogene controls the intra-Golgi recycling of sphingolipid glycosylating enzymes to promote proliferation 67
Immunohistochemistry for cancer stem cells detection: Principles and methods 66
Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization-based assay: Cytological smears versus cell blocks 66
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma 66
COVID-19: detection methods in post-mortem samples 64
Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era 64
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 62
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis 62
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 62
NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS 61
The value of ACR, European, Korean, and ATA ultrasound risk stratification systems combined with RAS mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules 58
Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy 56
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer 54
The Role of Toll-like Receptor-4 in Macrophage Imbalance in Lethal COVID-19 Lung Disease, and Its Correlation with Galectin-3 53
NTRK Gene Fusion Detection in Atypical Spitz Tumors 51
Multitarget fluorescence in situ hybridization diagnostic applications in solid and hematological tumors 49
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: A multi-institutional research study 49
RNAScope in situ Hybridization as a Novel Technique for the Assessment of c-KIT mRNA Expression in Canine Mast Cell Tumor 48
Detection of ROSI rearrangement in non-small cell lung cancer: Current and future perspectives 48
null 45
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 45
null 40
Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma 27
Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples 27
The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism 16
Totale 7.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021201 0 0 0 0 0 12 39 23 18 54 48 7
2021/2022478 5 12 3 4 121 7 30 10 21 48 75 142
2022/20231.085 126 36 20 87 98 80 11 52 519 14 18 24
2023/2024495 44 27 25 33 143 39 20 17 12 11 42 82
2024/20251.697 24 19 12 37 298 236 270 178 232 195 125 71
2025/20263.059 287 398 296 290 556 1.232 0 0 0 0 0 0
Totale 7.457